Recombinant Human EGR1/ZNF225 Protein，B2M & His

EGR1 (Early Growth Response 1) and ZNF225 (Zinc Finger Protein 225) are both transcription factors implicated in various biological processes, including cell growth, differentiation, and responses to stress. EGR1 is known for its role in immediate early gene expression, acting as a crucial regulator in neuronal development and synaptic plasticity. Its dysregulation has been linked to a variety of conditions, including cancer and neurodegenerative diseases. ZNF225, on the other hand, functions primarily in the regulation of gene expression through its zinc finger motifs, which facilitate the binding to DNA. The study of recombinant proteins of EGR1 and ZNF225 aims to explore their functional roles, molecular interactions, and regulatory mechanisms in cellular pathways. By expressing and purifying these proteins, researchers can conduct various biochemical assays to investigate their potential as targets for therapeutic interventions or as biomarkers for disease states. The recombinant approach also allows for the assessment of post-translational modifications and protein stability, which are critical for their functional activity. Understanding the interplay between EGR1 and ZNF225 may provide insights into their cooperative roles in transcriptional regulation and their implications in health and disease. This research holds promise for developing innovative strategies for managing diseases associated with their aberrant expression.